Stay updated on Effect of Oral AT1001 in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.

Latest updates to the Effect of Oral AT1001 in Fabry Disease Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a recruitment status note indicating enrollment has ended for this Fabry disease study. It also adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and includes a minor formatting/version update (Intervention/Treatment heading and Revision: v3.6.0).SummaryDifference0.4%

- Check10 days agoChange DetectedThe revision tag on the page updated from v3.5.4 to v3.5.5, signaling a new page revision. The change is a metadata/version update and does not modify the study details shown.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new Genet Med 2021 publication about migalastat-treated Fabry disease was added to the Publications list, and the revision tag was updated to v3.5.4, replacing the prior v3.5.3 entry that included an Erratum.SummaryDifference0.1%

- Check52 days agoChange DetectedThis page’s footer revision label was updated from “v3.5.2” to “v3.5.3.” This represents a system/version update rather than a change to the study record content.SummaryDifference0.0%

- Check60 days agoChange DetectedGenet Med publication citation updated to include an Erratum and revised to v3.5.2, replacing the previous v3.5.0 citation.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0. No visible changes to study details or page layout.SummaryDifference0.0%

Stay in the know with updates to Effect of Oral AT1001 in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.